EbenIsaacLichtmanMD
Hematology • Chapel Hill, NCHematologic Oncology
Clinical Instructor, University of North Carolina
Dr. Lichtman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
170 Manning Dr
Chapel Hill, NC 27514Phone+1 919-966-4431Fax+1 919-843-6949
Education & Training
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2015 - 2018
University of Massachusetts Medical SchoolClass of 2012
Certifications & Licensure
NC State Medical License 2015 - 2025
MA State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Association of p16(INK4a), a biomarker of cellular senescence, with receipt of therapy and frailty status among adults with plasma cell disorders.Christopher E Jensen, Allison M Deal, Shweta Srikanth, Kirsten A Nyrop, Natalia Mitin
Journal of Geriatric Oncology. 2024-12-20 - 1 citationsAn open-label, first-in-human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multi...Prashant Kapoor, Nitya Nathwani, Tomas Jelinek, Ludek Pour, Aurore Perrot
European Journal of Haematology. 2024-11-01 - Second Line Therapy in Multiple Myeloma: A SEER Medicare Analysis.Matthew R LeBlanc, Xi Zhou, Christopher D Baggett, Sascha A Tuchman, Christopher E Jensen
Clinical Lymphoma, Myeloma & Leukemia. 2024-09-01
Press Mentions
Researchers Identify Experimental Immunotherapy Approach to Target Acute Myeloid LeukemiaJanuary 7th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
